** GenScript Biotech jumps as much as 7.2% to HK$10.98, highest since Dec. 11, 2024
** Stock set for biggest one-day pct rise since Oct. 22, 2024 and is on course for sixth consecutive session of gains
** Co's associate Legend Biotech announces its drug CARVYKTI, used to treat cancer of the bone marrow, brought in ~$334 mln in net trade sales in quarter ended Dec. 31, 2024, up from year-ago $159 mln
** GenScript fell 50.5% last year
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))